title: Teriparatide fracture effectiveness in the real world.
authors.affiliation: Eli Lilly and Company, Lilly Corporate Center, Drop Code 1546, Indianapolis, IN, 46285, USA, krege_john_henry@lilly.com.
authors.forename: J H
authors.initials: JH
authors.lastname: Krege
authors.forename: R T
authors.initials: RT
authors.lastname: Burge
authors.forename: F
authors.initials: F
authors.lastname: Marin
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D005260:Female; D050723:Fractures, Bone / Q000453:epidemiology*; D006801:Humans; D007345:Insurance Claim Review; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy*; D058866:Osteoporotic Fractures / Q000453:epidemiology*; D019379:Teriparatide / Q000008:administration & dosage*
chemical_list: D050071:Bone Density Conservation Agents; D019379:Teriparatide